Five million Brits could be facing travel issues with their travel plans in the coming weeks over the type of jab they received, according to reports.
Britain relied heavily on the AstraZeneca vaccine in the early days of its vaccination rollout and raced into the lead in terms of the number of doses it handed out.
It is now facing a number of issues including rising COVID-19 cases and hospital admissions as a result of the prevalence of the Delta variant of the virus.
Ireland and many countries across Europe are beginning to experience a rise in case numbers as the variant is slowly becoming the dominant strain of the virus.
The efficacy of double doses of the likes of AstraZeneca are said to be high in terms of keeping people from being seriously ill or requiring hospitalisation.
Despite that, reports from the UK now suggest that some five million people who received specific doses of AstraZeneca could be blocked from travelling into Europe.
The Telegraph reports that Indian-made doses of that vaccine are not recognised by the European Union or the European Medicines Agency, which means those who received those jabs may not be covered for travel under the EU’s travel cert.
The type of jab not recognised by the EU is called Covishield and it is produced by Serum Institute of India.
Reports suggest that those jabs will be recognised by batch numbers that will show up on the COVID digital passport systems when people intend to travel.
Those who have received the Vaxevria version of the AstraZeneca jab, which is manufactured in the UK and Europe, will not have a problem as this jab is recognised by the EU.
A European Commission spokesperson told the publication: ‘Entry into the EU should be allowed to people fully vaccinated with one of the vaccines authorised in the EU.
‘Member states are… not required to issue certificates for a vaccine that is not authorised on their territory.’
Under the COVID-19 passport scheme, each individual EU member state does have the authority to recognise a vaccine that hasn’t been recognised by the EU, so ability to travel could be dictated by specific rules adopted by each state.